Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001179110-20-010689)

Filing Details

Accession Number:: 0001179110-20-010689
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-10-27 19:01:58
Reporting Period:: 2020-10-23

Accepted Time:: 2020-10-27 19:01:58
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
896264	Usana Health Sciences Inc	USNA	Medicinal Chemicals & Botanical Products (2833)	870500306

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1748208	Joshua Foukas	3838 West Parkway Blvd. Salt Lake City 84120	Chief Legal Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2020-10-23	315	$0.00	315	No	4	M	Direct
Common Stock	Disposition	2020-10-23	118	$85.86	197	No	4	F	Direct
Common Stock	Disposition	2020-10-26	197	$84.06	0	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	F	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Restricted Stock Units	Disposition	2020-10-23	315	$0.00	315	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
15,817			No	4	M	Direct

Footnotes

Each restricted stock unit represents a contingent right to receive one share of USNA common stock.
On October 23rd, 2017, the reporting person was granted 1,261 restricted stock units, vesting at 25% on each 23rd of October thereafter.